FIELD: biochemistry.
SUBSTANCE: invention relates to the field of biochemistry, particularly to an antibody or an antigen-binding fragment thereof, specifically binding with a hepatocyte growth factor receptor (c-Met). Also disclosed are a nucleic acid molecule encoding said antibody, an expression vector and a host cell containing said nucleic acid molecule, compositions for detecting c-Met and preventing or treating cancer, containing said antibody. Disclosed are methods for detecting c-Met antigen using said antibody, method for treating or preventing cancer using said antibody.
EFFECT: invention allows effectively treating cancer associated with overexpression of c-Met.
27 cl, 20 dwg, 28 tbl, 20 ex
Title | Year | Author | Number |
---|---|---|---|
NEW MODIFIED IMMUNOGLOBULIN Fc-FRAGMENT FUNCTION PROTEIN AND ITS USE | 2020 |
|
RU2800919C2 |
ANTI-CEACAM1 ANTIBODY AND ITS APPLICATION | 2018 |
|
RU2754876C2 |
ANTI-HER2/ANTI-4-1BB BISPECIFIC ANTIBODY AND USE THEREOF | 2020 |
|
RU2831838C2 |
BISPECIFIC ANTI-EGFR/ANTI-4-1BB ANTIBODY AND USE THEREOF | 2020 |
|
RU2831836C2 |
LONG-ACTING FUSION PROTEIN GDF15 AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | 2020 |
|
RU2836280C1 |
PROGRAMMED CELL DEATH (PD-1) PROTEIN-1 ANTIBODIES AND USE THEREOF | 2017 |
|
RU2725950C1 |
ANTIBODIES AGAINST PROGRAMMED CELL DEATH LIGAND 1 AND THEIR USE | 2020 |
|
RU2786235C1 |
SPECIFIC TO MUCIN-1 POLYPEPTIDE AND ITS USE | 2021 |
|
RU2805840C1 |
MODIFIED MITOCHONDRIA AND THEIR USE | 2019 |
|
RU2811467C2 |
IL4 RECEPTOR ANTIBODIES FOR USE IN VETERINARY SCIENCE | 2019 |
|
RU2837141C2 |
Authors
Dates
2021-07-16—Published
2018-05-30—Filed